Email
Password
Remember meForgot password?
    Log in with Twitter
| Press Release

Free Research Report as Medical Properties’ Quarterly Revenue Surged 34%; NFFO Advanced 19%

Stock Monitor: Universal Health Realty Income Trust Post Earnings Reporting

LONDON, UK / ACCESSWIRE / March 14, 2018 / Active-Investors.com has just released a free earnings report on Medical Properties Trust, Inc. (NYSE: MPW) ("MPT"). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=MPW. MPT reported its fourth quarter and fiscal 2017 operating and financial results on February 08, 2018. The health care real estate investment trust (REIT) exceeded revenue and funds from operations (FFO) expectations. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Universal Health Realty Income Trust (NYSE: UHT), which also belongs to the Financial sector as the Company Medical Properties Trust. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=UHT

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Medical Properties Trust most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=MPW

Earnings Highlights and Summary

For the fourth quarter 2017, MPT's total revenues surged 34% to $205.0 million compared to $153.3 million for Q4 2016. The Company's reported numbers topped analysts' estimates of $197.6 million.

MPT's revenue for the twelve months ended December 31, 2017, increased 30% to $704.7 million from $541.1 million in FY16.

MPT's net income for Q4 2017 was $71.9 million, or $0.19 per diluted share, compared to $43.0 million, or $0.13 per diluted share, in Q4 2016. The Company's normalized funds from operation (NFFO) for the reported quarter was $134.8 million, or $0.37 per diluted share, compared to $100.7 million, or a record $0.31 per diluted share, in the year earlier corresponding quarter. MPT's reported numbers surpassed Wall Street's estimates of $0.35 per share.

For FY17, MPT's net income was $289.8 million, or $0.82 per diluted share, for FY17 compared to net income of $225.0 million, or $0.86 per diluted share, in FY16. For FY17, MPT's NFFO totaled $474.9 million, or $1.35 per diluted share, from $334.8 million, or $1.28 per diluted share, in FY16.

Portfolio Update

During Q4 2017, MPT completed $95.0 million in real estate acquisitions and commenced funding the development of a $113.5 million acute care hospital. With these transactions and commitments, the Company has pro-forma total gross assets of approximately $9.5 billion including $6.6 billion in general acute care hospitals, $2.0 billion in inpatient rehabilitation hospitals, and $0.4 billion in long-term acute care hospitals.

MPT's pro-forma portfolio includes 276 properties representing more than 32,000 licensed beds in 29 states and in Germany, the United Kingdom, Italy, and Spain. The properties are leased to or mortgaged by 31 hospital operating companies.

During FY17, MPT closed approximately $2.2 billion in acquisitions compared to approximately $1.8 billion in FY16 and $1.7 billion in FY15, resulting in 34% compound annual growth in assets over the past three years.

Upcoming Dividend

On February 15, 2018, MPT announced that its Board of Directors declared a quarterly cash dividend of $0.25 per share of common stock to be paid on April 12, 2018, to stockholders of record on March 15, 2018.

Outlook

For full year 2018, MPT is forecasting net income in the range from $1.02 to $1.06 per diluted share and NFFO in the band of $1.42 to $1.46 per diluted share.

Stock Performance Snapshot

March 13, 2018 - At Tuesday's closing bell, Medical Properties Trust's stock marginally dropped 0.38%, ending the trading session at $13.20.

Volume traded for the day: 2.37 million shares, which was above the 3-month average volume of 2.35 million shares.

Stock performance in the last month – up 6.11%; and past twelve-month period – up 6.97%

After yesterday's close, Medical Properties Trust's market cap was at $4.78 billion.

Price to Earnings (P/E) ratio was at 16.02.

The stock has a dividend yield of 7.58%.

The stock is part of the Financial sector, categorized under the REIT - Healthcare Facilities industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors